Provide one-step panel/WES/WGS central lab servicefor clinical labs or other third parties

 

● >12 years medical NGS service experience (>600 employees)

● >600K rare disease patients diagnosed in China

● >5000 clinicians, >200 clinical labs serviced in China

● >Cloud based Al powered rare disease genomic reporting system (NuoYun)

Dr. Wu Jian

Founder and Chairman of MyGenostics

● BA, Chemical Biology, Peking University, China
● Ph.D, Genome Technology, Columbia University, USA
● Post Doc, Cancer Genetics, the Johns Hopkins University,USA

Core Technology - GenGap Gene Capture Technology

GenGap technology can capture human genome fragments flexibly and efficiently, combined with the next generation of high-throughput sequencing technology, it can be applied to large-scale gene research and screening.

1. One of the world's top three capture technology platforms, the earliest to realise deletion and duplication analysis through capture sequencing;
2. The earliest to use capture sequencing for genetic testing in China, effectively reducing sequencing costs;
3. The technology has reached the leading level in China,entered the stage of industrialization;
4. A platform for clinical mutation gene screening, diagnosis and personalized drug treatment genetic information was established in China
.

Outstanding scientific research transformation ability


-National Key Research and Development Program of China - 3

-Major Project of the Ministry of Science and Technology - 2

-Special Project of the Ministry of Science and Technology - 1

-SCI Academic Papers - 924

-Patents - 39

-Software Copyright - 80

-Commercialization of Scientific and Research Findings Award - 4